| Brand name |
Xalkori
|
|---|---|
| المخاطر |
• Breathing problems associated with interstitial lung disease and pneumonitis. • Light-headedness, fainting, chest discomfort or irregular heartbeat associated with bradycardia, QT prolongation and cardiac failure. • Abnormalities in liver blood tests associated with hepatotoxicity. • Visual changes, including guidance to assess visual symptoms in the paediatric population. • Stomach disorders associated with gastrointestinal perforation. |
| تاريخ الموافقة |
|
| Last updated date |
|
| المواد التعليمية الموجهة للمريض |
An official government website affiliated with the Government of the Kingdom of Saudi Arabia.
Beta version
Official Saudi government website domains end with gov.sa
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Official Reliable websites use HTTPS
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.